Positioning Early Phase CNS Trials for Investor Success

By | 24 March 2026
  • Rethinking early phase strategy for pivotal trial success
  • Expanding first-in-human to generate early proof-of-concept
  • Smarter protocol design: upfront investment, timelines and downstream ROI